Jennifer Smit to Anti-HIV Agents
This is a "connection" page, showing publications Jennifer Smit has written about Anti-HIV Agents.
Connection Strength
2,604
-
Use of tenofovir-based preexposure prophylaxis among pregnant women in South Africa. AIDS. 2025 Apr 01; 39(5):508-518.
Score: 0,508
-
Oral preexposure prophylaxis uptake, adherence, and persistence during periconception periods among women in South Africa. AIDS. 2024 07 15; 38(9):1342-1354.
Score: 0,488
-
Protocol for a prospective evaluation of postpartum engagement in HIV care among women living with HIV in South Africa. BMJ Open. 2020 01 09; 10(1):e035465.
Score: 0,360
-
Longitudinal Changes in Tenofovir and Tenofovir Diphosphate Concentrations Among Pregnant Women Using Oral PrEP for HIV Prevention: Findings From Durban, South Africa. J Acquir Immune Defic Syndr. 2025 Apr 01; 98(4):357-362.
Score: 0,129
-
Preferences for HIV pre-exposure prophylaxis formulations and delivery among young African women: results of a discrete choice experiment. J Int AIDS Soc. 2025 Feb; 28(2):e26422.
Score: 0,128
-
Post-trial access to and use of pre-exposure prophylaxis in Durban, South Africa. BMC Public Health. 2023 06 22; 23(1):1210.
Score: 0,114
-
Key stakeholders' perspectives on providing oral pre-exposure prophylaxis as HIV-prevention standard of care in clinical trials in South Africa. Afr J AIDS Res. 2023 Apr; 22(1):18-26.
Score: 0,112
-
Influences on PrEP Uptake and Adherence Among South African Women During Periconception and Pregnancy: A Qualitative Analysis. AIDS Behav. 2023 Jan; 27(1):208-217.
Score: 0,107
-
Brief Report: Quantifiable Plasma Tenofovir Among South African Women Using Daily Oral Pre-exposure Prophylaxis During the ECHO Trial. J Acquir Immune Defic Syndr. 2022 09 01; 91(1):26-30.
Score: 0,107
-
High Levels of Pretreatment HIV-1 Drug Resistance Mutations Among South African Women Who Acquired HIV During a Prospective Study. J Acquir Immune Defic Syndr. 2022 10 01; 91(2):130-137.
Score: 0,106
-
Exploring the Use of Oral Pre-exposure Prophylaxis (PrEP) Among Women from Durban, South Africa as Part of the HIV Prevention Package in a Clinical Trial. AIDS Behav. 2021 Apr; 25(4):1112-1119.
Score: 0,095
-
Integrating oral PrEP delivery among African women in a large HIV endpoint-driven clinical trial. J Int AIDS Soc. 2020 05; 23(5):e25491.
Score: 0,092
-
Protocol for a longitudinal study to evaluate the use of tenofovir-based PrEP for safer conception and pregnancy among women in South Africa. BMJ Open. 2019 07 26; 9(7):e027227.
Score: 0,087
-
Whoonga: potential recreational use of HIV antiretroviral medication in South Africa. AIDS Behav. 2014 Mar; 18(3):511-8.
Score: 0,060
-
Antiretrovirals and safer conception for HIV-serodiscordant couples. Curr Opin HIV AIDS. 2012 Nov; 7(6):569-78.
Score: 0,055
-
Self-reported removal and expulsion of the dapivirine vaginal ring: qualitative reports from female ring users and their male partners in the Ring Study (IPM 027). BMC Public Health. 2024 May 31; 24(1):1458.
Score: 0,031
-
Performance and Acceptability of the FC2 Female Condom When Used With and Without a Silicone Placebo Vaginal Ring-A Randomized, Crossover Trial. J Acquir Immune Defic Syndr. 2020 09 01; 85(1):58-65.
Score: 0,024